Open AccessMedicine

Charisse N. Winston, E. Goetzl, J. Akers, B. Carter, E. Rockenstein, D. Galasko, E. Masliah, R. Rissman

2016.5.7Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

DOI: 10.1016/j.dadm.2016.04.001

tlooto Summary

Levels of Alzheimer's disease‐related proteins in plasma neuronal derived exosomes (NDEs) were quantified to identify biomarkers for prediction and staging of mild cognitive impairment (MCI) and AD.

Abstract

Levels of Alzheimer's disease (AD)‐related proteins in plasma neuronal derived exosomes (NDEs) were quantified to identify biomarkers for prediction and staging of mild cognitive impairment (MCI) and AD.

Citation format

WINSTON, Charisse N., et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2016, 3: 63–72.